Hongye Co., Ltd., together with Jiangsu Hi-tech Venture Capital Co., Ltd. and other powerful institutions, established Hong Rui Science and Technology Venture Capital Co., Ltd. and actively entered the biomedical field. It has obvious advantages in traditional Chinese medicine, imitation of new chemical drugs, microbial fermentation engineering, cell engineering and enzyme engineering, and has good industrialization prospects. With the launch of GEM, once the company's venture capital projects can be successfully hatched and listed, the company is expected to gain huge profits.
Plastic futures officially listed on Dalian Commodity Exchange on Tuesday, which is the third new product in China futures market this year. A new army of futures trading varieties has brought new growth points to futures companies. According to historical experience, the introduction of new varieties often attracts great attention of investors, and the trading of plastic futures is expected to make great contributions to the performance of futures companies. At the same time, as the focus of everyone's attention, once launched, it will bring explosive growth to the profits of futures companies. At present, the preparations for stock index futures are being actively promoted, and the pace of stock index futures is getting closer and closer. Hongye shares in Jiangsu Hongye Futures Brokerage Company are expected to share the feast of plastic futures and stock index futures.
At present, the unit is running in the rising channel, and it is expected to accelerate the upswing in the short term, which can be focused on.